GENEVA (Reuters) - The Ebola outbreak in Congo is confirmed to be the Zaire strain of the virus and vaccinations of health workers may start as early as Wednesday, a senior official of the World ...

"It's a great example ... for a new vaccine that has enough preclinical safety and manufacturing quality control to be brought into the field at such an early stage," former ASTMH president Thomas ...

According to the World Health Organization (WHO) two cases of ebola fever have been confirmed in Liberia, which means that the highly contagious virus has started to spread from Guinea across West ...

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single ...

The World Health Organization (WHO) on Tuesday said it had prequalified an Ebola vaccine for the first time, hailing a "critical step" towards its licensing, access and roll-out in countries most at ...

LONDON (Reuters) - As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit ...

The World Health Organization (WHO) today prequalified an Ebola vaccine for the first time, a critical step that will help speed up its licensing, access and roll-out in countries most at risk of ...

In two randomized trials of Zaire Ebola vaccines, safety and immune responses in adults and children were assessed for three regimens with two different vaccines. All three induced immune responses ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Helen Branswell covers issues broadly related to infectious diseases, ...

The Peter Kim Lab was recently awarded $18 million by the Coalition for Epidemic Preparedness to create a vaccine to protect ...

Two vaccines against Zaire Ebola virus disease have received World Health Organization prequalification status. Questions about their safety and immunogenicity have persisted, however. New research ...